Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate vs midazolam for ICU sedation
ChiCTR2000038194Phase 4Recruiting
- Sponsor
- Xinyang Central Hospital
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam in sedation and critical illness (2 arms), sponsored by Xinyang Central Hospital. Primary endpoints: Sedation score and Vital signs. Started Oct 2020; status: recruiting.
02
Drugs
remimazolam
03
Conditions
sedationcritical illness
Beyond the preview
Go deeper on ChiCTR2000038194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038194.